Market capitalization of the largest public biotech companies jumps nearly 12% year-over-year, as all but five of them show ...

We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to ...

While 2024 was a "challenging" year for biotech stocks, JPMorgan is of the view that some names in the industry may be poised for considerable upside in the coming months.

We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to ...

Maria Zannes, who has held the CEO position at the San Antonio-based biotechnology company since 2014, will see a bump in pay ...

The biotech market offers great investment potential due to innovative advancements in genetic profiling, biologics, CRISPR ...

Roche's core research spans five large areas. Boris Zaïtra, who now leads corporate business development, is confident his ...

We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to ...

The facility, backed by UVA, CvilleBioHub and a $4.3 million GO Virginia award, will bring lab breakthroughs to health care.

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that its CEO, Steve ...

The U.S. Commerce Department said Wednesday it is imposing new export controls on biotechnology equipment and related ...

AI optimizes existing knowledge but doesn't expedite drug approval or reduce costs compared to traditional methods. Explore ...